Molecular Aspects and Clinical Relevance of GDF9 and BMP15 in Ovarian Function
Open Access
- 1 January 2018
- book chapter
- Published by Elsevier
- Vol. 107, 317-348
Abstract
No abstract availableKeywords
This publication has 141 references indexed in Scilit:
- Growth differentiation factor 9:bone morphogenetic protein 15 heterodimers are potent regulators of ovarian functionsProceedings of the National Academy of Sciences, 2013
- Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop GroupFertility and Sterility, 2012
- Signalling pathways mediating specific synergistic interactions between GDF9 and BMP15Molecular Human Reproduction, 2011
- Impaired production of BMP-15 and GDF-9 mature proteins derived from proproteins WITH mutations in the proregionMolecular and Cellular Endocrinology, 2010
- Stable expression and characterization of N-terminal tagged recombinant human bone morphogenetic protein 15Molecular Human Reproduction, 2009
- BMP15 mutations associated with primary ovarian insufficiency cause a defective production of bioactive proteinHuman Mutation, 2009
- Variation in bone morphogenetic protein 15 is not associated with spontaneous human dizygotic twinningHuman Reproduction, 2008
- Analyses of GDF9 mutation in 100 Chinese women with premature ovarian failureFertility and Sterility, 2007
- A unique preovulatory expression pattern plays a key role in the physiological functions of BMP-15 in the mouseProceedings of the National Academy of Sciences, 2006
- Pituitary FSH is released by a heterodimer of the β-subunits from the two forms of inhibinNature, 1986